annual EBITDA:
$395.90M+$12.40M(+3.23%)Summary
- As of today (May 29, 2025), ACA annual EBITDA is $395.90 million, with the most recent change of +$12.40 million (+3.23%) on December 31, 2024.
- During the last 3 years, ACA annual EBITDA has risen by +$144.60 million (+57.54%).
- ACA annual EBITDA is now -21.03% below its all-time high of $501.30 million, reached on December 31, 2022.
Performance
ACA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$111.10M+$4.90M(+4.61%)Summary
- As of today (May 29, 2025), ACA quarterly EBITDA is $111.10 million, with the most recent change of +$4.90 million (+4.61%) on March 1, 2025.
- Over the past year, ACA quarterly EBITDA has increased by +$12.70 million (+12.91%).
- ACA quarterly EBITDA is now -54.58% below its all-time high of $244.60 million, reached on December 31, 2022.
Performance
ACA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$408.60M+$12.70M(+3.21%)Summary
- As of today (May 29, 2025), ACA TTM EBITDA is $408.60 million, with the most recent change of +$12.70 million (+3.21%) on March 1, 2025.
- Over the past year, ACA TTM EBITDA has increased by +$42.50 million (+11.61%).
- ACA TTM EBITDA is now -25.10% below its all-time high of $545.50 million, reached on March 31, 2023.
Performance
ACA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ACA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.2% | +12.9% | +11.6% |
| 3 y3 years | +57.5% | +55.2% | +51.8% |
| 5 y5 years | +65.4% | +54.1% | +60.7% |
ACA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.0% | +57.5% | -54.6% | +55.2% | -25.1% | +51.8% |
| 5 y | 5-year | -21.0% | +65.4% | -54.6% | +149.1% | -25.1% | +72.1% |
| alltime | all time | -21.0% | +142.1% | -54.6% | +374.8% | -25.1% | +710.7% |
ACA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $111.10M(+4.6%) | $408.60M(+3.2%) |
| Dec 2024 | $395.90M(+3.2%) | $106.20M(+32.6%) | $395.90M(+5.8%) |
| Sep 2024 | - | $80.10M(-28.0%) | $374.10M(-2.6%) |
| Jun 2024 | - | $111.20M(+13.0%) | $384.20M(+4.9%) |
| Mar 2024 | - | $98.40M(+16.6%) | $366.10M(-4.5%) |
| Dec 2023 | $383.50M(-23.5%) | $84.40M(-6.4%) | $383.50M(-29.5%) |
| Sep 2023 | - | $90.20M(-3.1%) | $543.70M(+0.3%) |
| Jun 2023 | - | $93.10M(-19.6%) | $542.30M(-0.6%) |
| Mar 2023 | - | $115.80M(-52.7%) | $545.50M(+8.8%) |
| Dec 2022 | $501.30M(+99.5%) | $244.60M(+175.5%) | $501.30M(+61.9%) |
| Sep 2022 | - | $88.80M(-7.8%) | $309.60M(+4.2%) |
| Jun 2022 | - | $96.30M(+34.5%) | $297.20M(+10.4%) |
| Mar 2022 | - | $71.60M(+35.3%) | $269.10M(+7.1%) |
| Dec 2021 | $251.30M | $52.90M(-30.8%) | $251.30M(+3.4%) |
| Sep 2021 | - | $76.40M(+12.0%) | $243.00M(+2.4%) |
| Jun 2021 | - | $68.20M(+26.8%) | $237.40M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $53.80M(+20.6%) | $245.00M(-7.0%) |
| Dec 2020 | $263.30M(+10.0%) | $44.60M(-37.0%) | $263.30M(-3.0%) |
| Sep 2020 | - | $70.80M(-6.6%) | $271.50M(+2.1%) |
| Jun 2020 | - | $75.80M(+5.1%) | $265.90M(+4.6%) |
| Mar 2020 | - | $72.10M(+36.6%) | $254.20M(+6.2%) |
| Dec 2019 | $239.40M(+46.4%) | $52.80M(-19.0%) | $239.40M(+2.2%) |
| Sep 2019 | - | $65.20M(+1.7%) | $234.20M(+21.7%) |
| Jun 2019 | - | $64.10M(+11.9%) | $192.40M(+10.9%) |
| Mar 2019 | - | $57.30M(+20.4%) | $173.50M(+6.1%) |
| Dec 2018 | $163.50M(-16.5%) | $47.60M(+103.4%) | $163.50M(+5.6%) |
| Sep 2018 | - | $23.40M(-48.2%) | $154.90M(-14.8%) |
| Jun 2018 | - | $45.20M(-4.4%) | $181.90M(+33.1%) |
| Mar 2018 | - | $47.30M(+21.3%) | $136.70M(+52.9%) |
| Dec 2017 | $195.80M(-25.5%) | $39.00M(-22.6%) | $89.40M(+77.4%) |
| Sep 2017 | - | $50.40M | $50.40M |
| Dec 2016 | $262.80M(-8.6%) | - | - |
| Dec 2015 | $287.40M | - | - |
FAQ
- What is Arcosa annual EBITDA?
- What is the all time high annual EBITDA for Arcosa?
- What is Arcosa annual EBITDA year-on-year change?
- What is Arcosa quarterly EBITDA?
- What is the all time high quarterly EBITDA for Arcosa?
- What is Arcosa quarterly EBITDA year-on-year change?
- What is Arcosa TTM EBITDA?
- What is the all time high TTM EBITDA for Arcosa?
- What is Arcosa TTM EBITDA year-on-year change?
What is Arcosa annual EBITDA?
The current annual EBITDA of ACA is $395.90M
What is the all time high annual EBITDA for Arcosa?
Arcosa all-time high annual EBITDA is $501.30M
What is Arcosa annual EBITDA year-on-year change?
Over the past year, ACA annual EBITDA has changed by +$12.40M (+3.23%)
What is Arcosa quarterly EBITDA?
The current quarterly EBITDA of ACA is $111.10M
What is the all time high quarterly EBITDA for Arcosa?
Arcosa all-time high quarterly EBITDA is $244.60M
What is Arcosa quarterly EBITDA year-on-year change?
Over the past year, ACA quarterly EBITDA has changed by +$12.70M (+12.91%)
What is Arcosa TTM EBITDA?
The current TTM EBITDA of ACA is $408.60M
What is the all time high TTM EBITDA for Arcosa?
Arcosa all-time high TTM EBITDA is $545.50M
What is Arcosa TTM EBITDA year-on-year change?
Over the past year, ACA TTM EBITDA has changed by +$42.50M (+11.61%)